SCHEMBL7652902

SCHEMBL7652902

NC(=S)Nc1nc2c(s1)Cc1cc(Cl)ccc1-2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 15/20 0.53
TP53 P04637 7/20 0.51
LMNA P02545 2/20 0.51
ALDH1A1 P00352 6/20 0.49
SMN1; SMN2 Q16637 6/20 0.49
NPC1 O15118 4/20 0.49
RAB9A P51151 4/20 0.49
TDP2 O95551 2/20 0.49
HSD17B10 Q99714 2/20 0.49
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
APAF1 O14727 4/20 0.47
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
BLM P54132 2/20 0.47
CASP3 P42574 1/20 0.47
MCL1 Q07820 1/20 0.47
SENP8 Q96LD8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL7650921 0.99 MAPT (0.53) MAPTTP53LMNAALDH1A1SMN1; SMN2
SCHEMBL6653595 0.81 MAPT (0.48) MAPTTP53LMNAALDH1A1SMN1; SMN2
SCHEMBL4958350 0.78 MAPT (0.68) MAPTTP53LMNAALDH1A1SMN1; SMN2
SCHEMBL6653588 0.78 MAPT (0.49) MAPTTP53LMNAALDH1A1SMN1; SMN2
SCHEMBL6648041 0.77 MAPT (0.50) MAPTTP53LMNAALDH1A1SMN1; SMN2
SCHEMBL6649263 0.77 MAPT (0.47) MAPTTP53LMNAALDH1A1SMN1; SMN2
SCHEMBL5573260 0.76 ADORA1 (0.67) ADORA1
Iodide SCHEMBL4960121 0.74 ADORA1 (0.69) ADORA1
SCHEMBL8666248 0.73 MAPT (0.64) MAPTTP53LMNAALDH1A1SMN1; SMN2
SCHEMBL6191569 0.73 ADORA1 (0.50) MAPTTP53LMNAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1161120-C Use of polycyclic 2-aminothiazole systems for the preparation of medicaments for the prophylaxis or treatment of obesity ���ĵ�˹ҩ��¹����޹�˾ 2004-08-11 CN disclosed
US-6476059-B1 Use of polycyclic 2-aminothiazole systems for the treatment of obesity AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-11-05 US disclosed
CN-1349404-A Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis treatment of obesity AVENTIS PHARMA GMBH (DE) 2002-05-15 CN disclosed